Sanofi takes 26.4% stake in Cheplapharm in mature drugs partnership - SNY News | RalliesSanofi takes 26.4% stake in Cheplapharm in mature drugs partnership
S
SNY• Sanofi and Cheplapharm form mature medicines partnership
- Sanofi will take a 26.4% equity stake in Cheplapharm under a proposed strategic partnership for mature medicines.
- Cheplapharm would acquire a portfolio of 20 mature drugs from Sanofi, with Lovenox/Clexane included outside the U.S.
- Three manufacturing sites would transfer to Cheplapharm in Hungary, Singapore, and France, with commercial transfer targeted for Q1 2027.
- The transaction is expected to close in Q3 2027, subject to employee consultations, regulatory approvals, and closing conditions.
- No impact is expected on Sanofi’s 2026 financial guidance; additional financial terms will be disclosed later.
•
